Below are highlights of recent postings to The Healthcare Investor blog which features insights and original content by McGuireWoods' Healthcare Private Equity attorneys Amber Walsh and Krist Werling on issues and trends that impact investments in healthcare and life sciences businesses.
FDA 510(k) Changes Impact Investments in Medical Device Companies
A Perspective From the Inside: An Interview with Trey Crabb of Health Strategy Partners
2011 JP Morgan Healthcare Conference Observations
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.